Cargando…
Mucosal delivery of anti-inflammatory IL-1Ra by sporulating recombinant bacteria
BACKGROUND: Mucosal delivery of therapeutic protein drugs or vaccines is actively investigated, in order to improve bioavailability and avoid side effects associated with systemic administration. Orally administered bacteria, engineered to produce anti-inflammatory cytokines (IL-10, IL-1Ra), have sh...
Autores principales: | Porzio, Stefano, Bossù, Paola, Ruggiero, Paolo, Boraschi, Diana, Tagliabue, Aldo |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2004
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC534112/ https://www.ncbi.nlm.nih.gov/pubmed/15516267 http://dx.doi.org/10.1186/1472-6750-4-27 |
Ejemplares similares
-
In vivo mucosal delivery of bioactive human interleukin 1 receptor antagonist produced by Streptococcus gordonii
por: Ricci, Susanna, et al.
Publicado: (2003) -
INNAMORA, a European Workshop focussed on the mechanisms of innate immunity in pathogen–host interaction and their exploitation in novel mucosal immunisation strategies
por: Boraschi, Diana, et al.
Publicado: (2003) -
Cause or consequence? The role of IL-1 family cytokines and receptors in neuroinflammatory and neurodegenerative diseases
por: Boraschi, Diana, et al.
Publicado: (2023) -
Increased Mucosal IL-22 Production of an IL-10RA Mutation Patient Following Anakinra Treatment Suggests Further Mechanism for Mucosal Healing
por: Li, Jian, et al.
Publicado: (2017) -
Expression and characterization of recombinant IL-1Ra in Aspergillus oryzae as a system
por: Mahmoudi Azar, Lena, et al.
Publicado: (2023)